Company intelligence / Profile preview

Sobereye

Menlo Park, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Sobereye's OPTOVERA platform is commercially deployed for workplace safety, enabling rapid, real-time detection of employee impairment risk—including fatigue, sleep deprivation, and substance use—via smartphone-based biometric eye measurements. Clinical/regulatory trial data is not applicable as the offering is classified as a health/safety device/software, not a therapeutic.

Therapeutic areas: NeurologyPsychiatryOther
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Solaris

Beyond the preview

Go deeper on Sobereye.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sobereye.

Explore the full profile